Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Transgene SA (TNG) NPV

Sell:€1.31 Buy:€1.38 Change: €0.03 (2.27%)
Market closed |  Prices as at close on 30 October 2020 | Switch to live prices |
Sell:€1.31
Buy:€1.38
Change: €0.03 (2.27%)
Market closed |  Prices as at close on 30 October 2020 | Switch to live prices |
Sell:€1.31
Buy:€1.38
Change: €0.03 (2.27%)
Market closed |  Prices as at close on 30 October 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. These products use viral vectors to directly or indirectly destroy diseased cells. The Company has approximately three products in clinical development: two immunotherapy products for cancer treatment and an anti-infective immunotherapy product for chronic hepatitis B. The Company also has various other programs based on its viral vector technology in research or in pre-clinical or clinical development. The Company's activities are focused on human health and, in particular, the research and development of immunotherapy products, including therapeutic vaccines and oncolytic viruses in the field of cancer and infectious diseases. The Company's principal products include TG4010 (MVA-MUC1-IL2), Pexa-Vec (VV-TK-GM-CSF), TG6002 (VV-TK-RR-FCU1), TG1050 (Ad5-HBV) and TG4001 (MVA-HPV-IL2).

Contact details

Address:
400 Boulevard Gonthier d'Andernach
Parc d'Innovation - CS80166
ILLKIRCH-GRAFFENSTADEN
67405
France
Telephone:
+33 (3) 88279100
Website:
https://www.transgene.fr

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TNG
ISIN:
FR0005175080
Market cap:
€111.01 million
Shares in issue:
83.84 million
Sector:
Biotechnology
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
n/a

Key personnel

  • Philippe Archinard
    Chairman of the Board, Chief Executive Officer, Member of the Management Committee
  • Christophe Ancel
    Vice President - Responsible Pharmacist, Quality and Deputy CEO, Member of the Management Committee
  • Jean-Philippe Del
    Vice President - Finance, Member of the Management Committee
  • Eric Quemeneur
    Executive Vice President, Director of Research & Development, Member of the Management Committee
  • Thibaut du Fayet
    Vice President Strategic Alliance, Project Management and Marketing, Member of the Management Committee
  • Maud Brandely
    Member of the Management Committee, Vice President - Clinical Development, Clinical Operations and Regulatory Affairs
  • Hemanshu Shah
    Vice President - Medical Affairs and International Development, Member of the Management Committee
  • John Felitti
    General Counsel, Member of the Management Committee, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.